Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Government Mechanics

USASpending

The federal government's open database of every contract, grant, and award, a goldmine for tracking who gets paid.

Also known as: USASpending.gov, Federal Spending Data

What it is
USASpending.gov is the official public database of federal awards, obligations, and outlays. It records who received money, from which agency, and for what. It draws on FPDS and other systems for near-authoritative award data.
What it does
It lets investors verify contract awards, track obligation trends by vendor, and confirm which public company actually won federal dollars. This turns press-release noise into checkable data. Rising obligations to a named contractor can foreshadow revenue.
The evidence
Analysts cross-reference USASpending obligations against company disclosures to validate federal revenue exposure for primes and subs.
Best for
Federal-exposed names like LDOS, GD, LMT, LHX, HII.
Pairs well with
idiq-contract, sole-source-contract, ndaa
Use cautiously with
Data lags reporting and can misattribute subcontract flows; the named prime is not always the ultimate beneficiary.
Cautions
Obligations are not yet outlays, so booked-to-revenue timing varies widely.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo